Search

everythinglearnresearchcommunity

for

Search:↓

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

Tamoxifen effectively treats gynecomastia without causing impotence.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Chemotherapy can cause significant hair thinning and changes in hair texture, while tamoxifen has a smaller effect.

Tamoxifen caused hair loss in a 52-year-old woman.

Hair and scalp pain is more common and severe in breast cancer patients on chemotherapy than those on tamoxifen.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Certain nutraceuticals may enhance hair growth without affecting the cancer-fighting properties of tamoxifen.

Hair growth-promoting nutraceuticals do not block the cancer-fighting effects of tamoxifen and may enhance its action.

Hair growth supplements do not reduce the effectiveness of the breast cancer treatment tamoxifen.

A 5-year-old girl with McCune-Albright syndrome grew abnormal hair due to the drug tamoxifen.

Cyproterone slightly inhibited hair growth in castrated mice, while tamoxifen significantly inhibited hair growth in castrated mice but not in normal mice.

Eye exams are crucial for kids with 13q deletion syndrome, tamoxifen can cause vision loss, Propecia may lead to cataracts, Lipoid Proteinosis causes skin bumps, and OCT is useful for diagnosing macular diseases.

Multiple eye conditions were studied, highlighting the importance of various imaging methods for diagnosis, the vision side effects of drugs tamoxifen and Propecia, and the usefulness of optical coherence tomography for diagnosing and monitoring macular and retinal diseases.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Hair follicle dermal stem cells are key for regenerating parts of the hair follicle and determining hair type.

YAP and TAZ proteins are necessary for the development of two types of skin cancer.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Fulvestrant is a well-tolerated new treatment for advanced breast cancer that may delay chemotherapy.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

Mice with LSS deficiency showed hair loss and cataracts, similar to humans, and can help in understanding and treating this condition.

Injury changes how hair follicle stem cells behave, depending on the hair growth stage.

A baby boy with 13q deletion syndrome had eye cancer, a woman's vision improved after stopping a breast cancer drug, a man developed cataracts from using Propecia, and a rare skin disorder called Lipoid Proteinosis was discussed. Also, a tool called OCT is useful for diagnosing macular diseases.

Oncogenic K-ras causes rapid cancerous changes in the mouth's lining.